MINI FUTURE LONG - STRYKER CORP. Share Price

Certificat

DE000PH7AVN7

Delayed Deutsche Boerse AG 04:51:14 20/05/2024 pm IST
15.5 EUR +0.91% Intraday chart for MINI FUTURE LONG - STRYKER CORP.
Current month-3.70%
1 month-3.94%
Date Price Change
20/24/20 15.5 +0.91%
17/24/17 15.36 0.00%
16/24/16 15.36 +2.33%
15/24/15 15.01 +3.88%
14/24/14 14.45 -0.28%

Delayed Quote Deutsche Boerse AG

Last update May 20, 2024 at 04:51 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PH7AVN
ISINDE000PH7AVN7
Date issued 19/11/2021
Strike 167.7 $
Maturity Unlimited
Parity 10 : 1
Emission price 10.77
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 18.05
Lowest since issue 4.48
Spread 0.15
Spread %0.96%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
334.7 USD
Average target price
372.4 USD
Spread / Average Target
+11.26%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW